Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer

MLA

Nishimiya Hiroshi, et al. “Therapeutic Potential of PRL-3 Targeting and Clinical Significance of PRL-3 Genomic Amplification in Gastric Cancer.” BMC Cancer, vol. 11, no. 1, Apr. 2011, p. 122. EBSCOhost, https://doi.org/10.1186/1471-2407-11-122.

APA

Nishimiya Hiroshi, Kawamata Hiroshi, Waraya Mina, Katada Natsuya, Sakuramoto Shinichi, Kikuchi Shiro, Yamashita Keishi, Ooki Akira, Nakamura Kazunori, & Watanabe Masahiko. (2011). Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer. BMC Cancer, 11(1), 122. https://doi.org/10.1186/1471-2407-11-122

Chicago

Nishimiya Hiroshi, Kawamata Hiroshi, Waraya Mina, Katada Natsuya, Sakuramoto Shinichi, Kikuchi Shiro, Yamashita Keishi, Ooki Akira, Nakamura Kazunori, and Watanabe Masahiko. 2011. “Therapeutic Potential of PRL-3 Targeting and Clinical Significance of PRL-3 Genomic Amplification in Gastric Cancer.” BMC Cancer 11 (1): 122. doi:10.1186/1471-2407-11-122.